Biogen alums, MacArthur ‘genius’ launch new biotech with $50M

Nereid Therapeutics launched Monday with a $50 million investment from Apple Tree to expand on Princeton University professor Clifford Brangwynne’s research exploring cellular function and biomolecular condensates.